Literature DB >> 20228266

Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Harry R Hill1, Nancy H Augustine, Robert J Pryor, Gudrun H Reed, Joshua D Bagnato, Anne E Tebo, Jeffrey M Bender, Brian M Pasi, Javier Chinen, I Celine Hanson, Martin de Boer, Dirk Roos, Carl T Wittwer.   

Abstract

High-resolution melting analysis was applied to X-linked chronic granulomatous disease, a rare disorder resulting from mutations in CYBB. Melting curves of the 13 PCR products bracketing CYBB exons were predicted by Poland's algorithm and compared with observed curves from 96 normal individuals. Primer plates were prepared robotically in batches and dried, greatly simplifying the 3- to 6-hour workflow that included DNA isolation, PCR, melting, and cycle sequencing of any positive products. Small point mutations or insertions/deletions were detected by mixing the hemizygous male DNA with normal male DNA to produce artificial heterozygotes, whereas detection of gross deletions was performed on unmixed samples. Eighteen validation samples and 22 clinical kindreds were analyzed for CYBB mutations. All blinded validation samples were correctly identified. The clinical probands were identified after screening for neutrophil oxidase activity. Nineteen different mutations were found, including seven near intron-exon boundaries predicting splicing defects, five substitutions within exons, three small deletions predicting premature termination, and four gross deletions of multiple exons. Ten novel mutations were found, including (c.) two missense (730T>A, 134T>G), one nonsense (90C>A), four splice site defects (45 + 1G>T, 674 + 4A>G, 1461 + 2delT, and 1462-2A>C), two small deletions (636delT, 1661_1662delCT), and one gross deletion of exons 6 to 8. High-resolution melting can provide timely diagnosis at low cost for effective clinical management of rare, genetic primary immunodeficiency disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228266      PMCID: PMC2860474          DOI: 10.2353/jmoldx.2010.090147

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  45 in total

1.  Hematologically important mutations: X-linked chronic granulomatous disease (second update).

Authors:  P G Heyworth; J T Curnutte; J Rae; D Noack; D Roos; E van Koppen; A R Cross
Journal:  Blood Cells Mol Dis       Date:  2001 Jan-Feb       Impact factor: 3.039

2.  The LightTyper: high-throughput genotyping using fluorescent melting curve analysis.

Authors:  C D Bennett; M N Campbell; C J Cook; D J Eyre; L M Nay; D R Nielsen; R P Rasmussen; P S Bernard
Journal:  Biotechniques       Date:  2003-06       Impact factor: 1.993

3.  Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis.

Authors:  Gudrun H Reed; Carl T Wittwer
Journal:  Clin Chem       Date:  2004-08-12       Impact factor: 8.327

4.  Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes.

Authors:  Mark G Herrmann; Jacob D Durtschi; L Kathryn Bromley; Carl T Wittwer; Karl V Voelkerding
Journal:  Clin Chem       Date:  2006-01-19       Impact factor: 8.327

5.  Recursion relation generation of probability profiles for specific-sequence macromolecules with long-range correlations.

Authors:  D Poland
Journal:  Biopolymers       Date:  1974       Impact factor: 2.505

Review 6.  Clinical aspects of chronic granulomatous disease.

Authors:  R B Johnston
Journal:  Curr Opin Hematol       Date:  2001-01       Impact factor: 3.284

7.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

8.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  CYBB mutation analysis in X-linked chronic granulomatous disease.

Authors:  Orathai Jirapongsananuruk; Julie E Niemela; Harry L Malech; Thomas A Fleisher
Journal:  Clin Immunol       Date:  2002-07       Impact factor: 3.969

10.  High-resolution genotyping by amplicon melting analysis using LCGreen.

Authors:  Carl T Wittwer; Gudrun H Reed; Cameron N Gundry; Joshua G Vandersteen; Robert J Pryor
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

View more
  7 in total

1.  Towards routine screening of rare genetic diseases: the example of chronic granulomatous disease.

Authors:  Marie José Stasia
Journal:  J Mol Diagn       Date:  2010-03-19       Impact factor: 5.568

Review 2.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

Review 3.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

4.  Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families.

Authors:  Marie José Stasia; Karin van Leeuwen; Martin de Boer; Cecile Martel; Michele Mollin; Isabelle Thuret; Gerard Michel; Celine Hanson; Nancy H Augustine; Charles Coutton; Véronique Satre; Carl T Wittwer; Harry Hill; Dirk Roos
Journal:  J Clin Immunol       Date:  2012-03-02       Impact factor: 8.542

5.  Application of high-resolution DNA melting for genotyping in lepidopteran non-model species: Ostrinia furnacalis (Crambidae).

Authors:  FengBo Li; BaoLong Niu; YongPing Huang; ZhiQi Meng
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

6.  Residual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous disease.

Authors:  Maria J Gutierrez; George D McSherry; Faoud T Ishmael; Alexandra A Horwitz; Gustavo Nino
Journal:  Case Rep Pediatr       Date:  2012-11-05

7.  Efficient method of genotyping ob/ob mice using high resolution melting analysis.

Authors:  Alton G Sutter; Arun P Palanisamy; Nichole Kurtz; Demetri D Spyropoulos; Kenneth D Chavin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.